About

The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.
 

Articles

Obesity in Asia-Pacific

Published:

05 June 2024

Citation:

Journal of Asian Pacific Society of Cardiology 2024;3:e21.

Cardiometabolic Risk Factors and COVID-19 in the Asia-Pacific Region

Published:

23 June 2023

Citation:

Journal of Asian Pacific Society of Cardiology 2023;2:e22.

Efficacy of Cryoablation in Patients with Obesity

Published:

30 June 2022

Citation:

Journal of Asian Pacific Society of Cardiology 2022;1:e15.